Presentation is loading. Please wait.

Presentation is loading. Please wait.

Croda International Plc Results for 6 months to 30 June 2003.

Similar presentations


Presentation on theme: "Croda International Plc Results for 6 months to 30 June 2003."— Presentation transcript:

1 Croda International Plc Results for 6 months to 30 June 2003

2 Summary 3% volume growth in Personal and Health Care sales Margins strong £8m reduction in debt to £43.7m

3 Summary of continuing operations Sales150.1151.4 Operating profit22.321.6 Interest(1.7)(2.3) Profit before tax 20.619.3 20032002 £m £m

4 Statistics 2003 2002 EPS normalised (p)9.99.3 DPS (p)4.023.91 Interest cover (x)12.89.3 Tax rate (%)35.535.9

5 Sales by destination* 2003 2002 £m%£m% United Kingdom22.91525.117 Rest of Europe48.83340.227 Americas45.63052.134 Asia19.31320.213 Rest of World13.5913.89 ______________ 150.1100151.4100 ______________________________ * continuing operations only

6 Sales by market* Personal & Health Care83.75682.955 Home Care & Plastics Additives21.51422.415 Industrial Specialities28.21928.018 Other16.71118.112 _________ ________ ________ ________ 150.1100 151.4100 _________ ________ ________ ________ * continuing operations only 20032002 £m% £m %

7 Turnover change on prior year* Volume Currency Mix/ Total price Group- 7.0%- 2.0%+ 8.0%- 1.0% * continuing operations only

8 Value/volume change on prior year* % ofValueVolume Sales % % 56Personal & Health Care +1 +3 14Home Care and Plastics Additives - 4 -13 19Industrial Specialities + 1 + 1 11Other - 8 - 17 ________ 100 _________ * continuing operations only

9 Oleochemicals trading margin* * continuing operations only

10 Cash flow £m 20032002 Operating cash flow25.720.8 Interest(1.7)(2.3) Dividends(4.5)(4.2) Taxation(7.0)(6.9) _______ _______ Free cash flow12.57.4 Net Capex(4.4)(8.4) Own shares(0.6)(0.3) Disposals/Acquisitions/Closures (0.4)0.1 _______ _______ Net cash flow7.1(1.2) Other1.31.5 _______ _______ Reduction in net debt8.40.3 _______ _______

11 Summary of trading Personal and Health Care driving growth Positive price/mix effect USA a little slower Europe stronger

12 Business development

13 New Personal Care products Unislim Lumiskin Stevia

14 Silhouette Sculptor for men and women UNISLIM TM

15 UNISLIM  Complex of 2 plants with slimming properties Green coffee (Cafestol + Kahweol) Yerba Mate (Methyl-xanthine)

16 UNISLIM  : 2-way active Lipolysis Activation Decrease of lipid entry Phosphodiesterase inhibition  Presence of lipid receptors on the cell membrane DESTOCKING BLOCKS THE LIPID STORAGE Green coffeeYerba Mate

17 Average reduction: 0,8 cm Up to 1,9 cm Women’s Thighs perimeter BeforeAfter

18 Men’s Volume of folds of fat -17,7 cm 3

19 Lumiskin LUMISKIN  give fairness to your skin

20 Control566ppm Kojic Acid25ppm DAB Inhibition of tyrosinase activity and melanin production on B16 cells IN VITRO Lumiskin

21 SkinEthic  3D model of epidermis type VI EX VIVO Cross sections Control Lumiskin  1.25% Lumiskin  4% Lumiskin

22 COLORIMETRIC TEST ON PIGMENTATION SPOTS IN VIVO Before Lumiskin After Before

23 Stevia Stevia rebaudiana From Brazil and Paraguay Skin moisturiser Emollient

24 + 14 % Moisturising Effect Stevia

25 Health Care Provensis update Natural asthma treatment launched H1 2003 Crohn’s disease - Phase III clinicals

26 Outlook Personal Care strong growth Health Care continues to progress Price increases holding Strong product pipeline


Download ppt "Croda International Plc Results for 6 months to 30 June 2003."

Similar presentations


Ads by Google